JIE MENG | Neuroscience | Best Researcher Award

Dr. JIE MENG | Neuroscience | Best Researcher Award 🏆

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education 🎓:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience 💼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimer’s disease and Parkinson’s disease.

Awards and Honors

Jie Meng’s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Meng’s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinson’s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinson’s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

📚 Publication 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

Conclusion 

In conclusion, to fully assess Dr. Jie Meng’s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Marjan Shariatpanahi | Neuroscience | Best Researcher Award

Dr Marjan Shariatpanahi |  Neuroscience | Best Researcher Award 

Associate professor at Iran university of medical sciences,Iran

Dr. Marjan Shariatpanahi is an Associate Professor in the Department of Pharmacology and Toxicology at the School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. With extensive experience in toxicology and pharmacology, Dr. Shariatpanahi has made significant contributions to research on neurodegenerative diseases and toxicology.

professional profile

scopus

google scholar

Education 🎓

Dr. Shariatpanahi holds a Doctor of Pharmacy (Pharm. D.) from Islamic Azad University, Tehran (2000-2006) with a thesis on thymidine phosphorylase and estrogen receptor alpha in colorectal cancer. She also earned a Ph.D. in Toxicology from Tehran University of Medical Sciences (2009-2014), focusing on the effects of PKG on spatial memory deficits and markers of autophagy and apoptosis in rats.

Work Experience 🏥

Dr. Shariatpanahi has a diverse professional background. She has been the Head of the Pharmacology & Toxicology Department at Iran University of Medical Sciences since 2017. Her previous roles include Dean of the Educational Office (2020-2023), Head of Student and Cultural Affairs (2019-2020), and faculty member at the Neuroscience Research Center (2018-present). She has also worked as an Assistant Professor at both Iran University of Medical Sciences and Guilan University of Medical Sciences, and as a Responsible Pharmacist in various institutions.

Skills 🛠️

Dr. Shariatpanahi is proficient in various research techniques, including IHC, Western blot, ICC, in vivo studies, and behavioral tests for neurodegenerative diseases. Her expertise extends to TLC, spectrophotometry, SPSS, PRISM, ELISA, and gas chromatography. She is also skilled in using atomic absorption machines and Endnote.

Awards and Honors 🏅

Dr. Shariatpanahi has received several accolades, including being named the best professor at the Vosough Festival of IUMS (2023) and being recognized as a selected pharmacist (2022). She was also acknowledged as a top student in toxicology and pharmacy, receiving first ranks in board examinations and seminars.

Professional Memberships 🔗

Dr. Shariatpanahi is a member of the Iranian Association of Toxicology, the Iranian Medical Council, the Iranian Association of Pharmacists, the Iranian Probiotics Society, and the Talent Society of Tehran University.

Teaching Experience 📚

Dr. Shariatpanahi has taught a wide range of courses across various levels. For Ph.D. students, she covers basics of pharmacology. For Doctor of Pharmacy students, she teaches toxicology, pharmacology, clinical toxicology, and specialized pharmacy language. Her M.Sc. teaching includes environmental toxicology, forensic toxicology, and advanced research methods, while for B.Sc. students, she focuses on toxicology.

Research Focus 🔬

Dr. Shariatpanahi’s research interests include neuroscience, with a focus on autism, Alzheimer’s disease, memory, and Parkinson’s disease. She is also involved in toxicology, environmental toxicology, pharmacology, cell signaling, stem cell therapy, and the study of behavioral investigations on animals. Her work explores various markers and mechanisms in carcinogenesis, angiogenesis, and the protective and toxic effects of nanoparticles.

Conclusion

Dr. Marjan Shariatpanahi’s extensive qualifications, leadership roles, significant research contributions, and recognition in the field make him an excellent candidate for the Best Researcher Award. His achievements demonstrate a strong commitment to advancing knowledge in pharmacology and toxicology, contributing valuable insights into neurodegenerative diseases, toxicology, and pharmacology.

publication